A. Higham (Manchester (Greater Manchester), United Kingdom), L. Uller (Lund, Sweden)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
GRC39815-A novel inhaled ROR?t inhibitor as a potential first in class treatment option for COPD
A. Kulkarni (Mahape, Navi Mumbai, Maharashtra, 400709, , India), S. Das (Mahape, Navi Mumbai, Maharashtra, 400709, , India), S. Shelke (Mahape, Navi Mumbai, Maharashtra, 400709, , India), S. Pardeshi (Mahape, Navi Mumbai, Maharashtra, 400709, , India), M. Bajpai (Mahape, Navi Mumbai, Maharashtra, 400709, , India), V. Potdar (Mahape, Navi Mumbai, Maharashtra, 400709, , India), S. Kadam (Mahape, Navi Mumbai, Maharashtra, 400709, , India), V. Bhosale (Mahape, Navi Mumbai, Maharashtra, 400709, , India), H. Patil (Mahape, Navi Mumbai, Maharashtra, 400709, , India), D. Behera (Mahape, Navi Mumbai, Maharashtra, 400709, , India), V. Udupa (Mahape, Navi Mumbai, Maharashtra, 400709, , India), K. Vinod (Mahape, Navi Mumbai, Maharashtra, 400709, , India), C. Caracta (750, Corporate Drive, Mahwah, NJ 07430, , United States of America), P. Iyer (Mahape, Navi Mumbai, Maharashtra, 400709, , India)
|   |
Beclomethasone, formoterol and glycopyrronium: synergy of dual and triple combinations in an ex vivo model of COPD exacerbation
L. Calzetta (Parma (PR), Italy), E. Puxeddu (Rome (RM), Italy), F. Facciolo (Rome (RM), Italy), P. Rogliani (Rome (RM), Italy)
| |
Adding glycopyrronium to beclomethasone/formoterol combination: synergistic effect on human medium bronchi of COPD donors
P. Rogliani (Roma (RM), Italy), J. Ora (Roma (RM), Italy), A. Girolami (Roma (RM), Italy), I. Rossi (Roma (RM), Italy), I. De Guido (Roma (RM), Italy), F. Facciolo (Roma (RM), Italy), M. Cazzola (Roma (RM), Italy), L. Calzetta (Parma (PR), Italy)
| |
Impact of Bronchial Rheoplasty on exacerbations in chronic bronchitis: a US feasibility study
V. Kim (Philadelphia, United States of America), G. Criner (Philadelphia, United States of America), F. Sciurba (Pittsburgh, United States of America), A. Comellas (Iowa City, United States of America), A. Majid (Boston, United States of America), K. Hogarth (Chicago, United States of America), N. Marchetti (Philadelphia, United States of America), M. Dransfield (Birmingham, United States of America)
| |
Bronchial Rheoplasty improves respiratory and sleep symptoms in chronic bronchitis
V. Kim (Philadelphia, United States of America), W. Krimsky (San Carlos, United States of America), B. Bannan (San Carlos, United States of America)
| |
Exploring the molecular potential of bacterial lysates to reduce COVID-19 susceptibility of bronchial epithelial cells in vitro
L. Fang (Basel, Switzerland), L. Zhou (Basel, Switzerland), M. Tamm (Basel, Switzerland), M. Roth (Basel, Switzerland)
| |
Imiquimod shows anti-viral actions in human bronchial epithelium - implications for COVID-19 treatment
S. Tillgren (Lund, Sweden), J. Nieto Fontarigo (Lund, Sweden), S. Cerps (Lund, Sweden), M. Hvidtfeldt (Copenhagen, Denmark), A. Sverrild (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark), L. Uller (Lund, Sweden)
| |
The effect of fluconazole on the pharmacokinetics of ensifentrine in healthy individuals
T. Rheault (Raleigh, United States of America), M. Kankam (Overland Park, United States of America), J. Ayrton (Abbots Langley, United Kingdom), T. Bengtsson (Lund, Sweden), K. Rickard (Raleigh, United States of America)
| |
1-?-alkyl-glycerols Reduce Level of Inflammatory Cytokines In Obese Asthma
Y. Denisenko (Vladivostok, Russian Federation), M. Antonyuk (Vladivostok, Russian Federation), A. Yurenko (Vladivostok, Russian Federation), T. Novgorodtseva (Vladivostok, Russian Federation), T. Gvozdenko (Vladivostok, Russian Federation), E. Mineeva (Vladivostok, Russian Federation), K. Sidletskaya (Vladivostok, Russian Federation), J. Perelman (Blagovechensk, Russian Federation), A. Prikhodko (Vladivostok, Russian Federation)
| |
The Impact of Conjugated Pneumococcal Vaccine on Exacerbation Frequency in Patients with COPD
Z. Öndes (IZMIR, Turkey), Y. Varol (IZMIR, Turkey), A. Cirak (IZMIR, Turkey), B. Hakoglu (IZMIR, Turkey), S. Tekgul (IZMIR, Turkey)
| |